MOLECULAR TARGETING TECHNOLOGIES, INC.

MOLECULAR TARGETING TECHNOLOGIES, INC. is a biotech company in WEST CHESTER, United States, founded in 2015. It has raised $141.6M across 5 rounds, most recently a $109.0M Venture Round in June 2024.

mtarget.com

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$141.6M
Last Round
$109.0M Venture RoundJun 2024
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds for this company. The full record is or through the API.

About

Molecular Targeting Technologies, Inc. (MTTI) is a privately held biotechnology company focused on the development of diagnostic and therapeutic molecules to address the unmet medical needs in cancer and infection. The company develops imaging, fusion protein, Geneseen, and PSVue technologies, and offers research product lines including CellVue, PSVue, NeuroVue, SRfluor, cyanines, IRIS, immobilized steroid beads, and CyAL optical probes.

Summary

It lists 1–10 employees. It has raised $141.6M in total across 5 rounds, most recently a $109.0M Venture Round in Jun 2024.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundJun 2024
$109.0M

Sign up to see all 5 events

Funding: Grant through Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MOLECULAR TARGETING TECHNOLOGIES, INC. on Indexed.vc
<a href="https://indexed.vc/companies/molecular-targeting-technologies-inc"><img src="https://indexed.vc/api/badge/company/molecular-targeting-technologies-inc" alt="MOLECULAR TARGETING TECHNOLOGIES, INC. on Indexed.vc" width="260" height="76" /></a>